Caribou Biosciences公布Antler I期试验的积极数据,证实Vispa-Cel (CB-010)的疗效和持久性,与自体CAR-T细胞疗法相媲美

美股速递
Nov 03, 2025

Caribou Biosciences公布Antler I期试验的积极数据,证实Vispa-Cel (CB-010)这款全源性CAR-T细胞疗法的疗效和持久性,与自体CAR-T细胞疗法相当。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10